Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...
A new daily pill will give people with stubbornly high cholesterol a cheaper, needle-free way to lower their levels.
A new pill to treat stubbornly high cholesterol has been approved by the Food and Drug Administration, a development that ...
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
This Saturday, July 11, pastor Greg Laurie’s Harvest Crusade will stream live on In Touch+ for the first time, broadcasting straight from Angel Stadium in Anaheim, California, from 7 to 9 p.m. PST.
Bronzed pork chops basted with butter, rosemary and shallot, plus corn plumped in the rendered drippings and browning butter — it doesn’t get better than this. Flipping the pork chops often helps them ...
Bronzed pork chops basted with butter, rosemary and shallot, plus corn plumped in the rendered drippings and browning butter -- it doesn't get better than this. Flipping the pork chops often helps ...
Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like. In this episode of The ...
Researchers in Italy conducted a multicentre retrospective observational study to compare the long-term efficacy and safety of tofacitinib, ustekinumab, and vedolizumab in 602 patients with UC who did ...
When newborns develop sepsis, doctors often have only hours to save them. But increasingly, known antibiotics are failing against drug-resistant bacteria, forcing clinicians to improvise with a ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A few weeks from now, we might have to eat our own words, or we might ...
Add Yahoo as a preferred source to see more of our stories on Google. Photo illustration of a group of weight loss medications on a white background. (Photo by: Michael Siluk/UCG/Universal Images ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results